Takeda Oncology
Adam Curet is an experienced professional in laboratory management and education, currently serving as the Laboratory Manager for the Oncology Drug Discovery Unit at Takeda Oncology since September 2023. Prior to this role, Adam held various positions at Vedanta Biosciences, Inc. from September 2019 to November 2023, advancing from Lab Manager to Senior Manager of Laboratory Operations and Environment, Health and Safety (EHS). Adam’s prior experience includes roles at QIAGEN as Lab Manager, as well as educational positions at Lawrence High School and Lawrence Public Schools, where responsibilities included full-time teaching in Honors and College Prep programs. Adam's earlier roles also include materials management at GKG SOLUTIONS LTD and manufacturing at OPK Biotech LLC. Adam earned a Bachelor's degree in History Teacher Education from UMass Boston between 2013 and 2016.
This person is not in any teams
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.